1-7 of 7
acute promyelocytic leukemia
Close
Sort by
Journal Articles

Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study

Clinical Trials & Observations
Harinder Gill, Yammy Yung, Hiu-Tung Chu, Wing-Yan Au, Pui-Kwan Yip, Emily Lee, Rita Yim, Paul Lee, Daniel Cheuk, Shau-Yin Ha, Rock Y. Y. Leung, Edmond S. K. Ma, Cyrus R. Kumana, Yok-Lam Kwong
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2829–2838.
https://doi.org/10.1182/bloodadvances.2021004789
Published: 2021
Includes: Supplemental data
Journal Articles

Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia

Clinical Trials & Observations
Douglas R. A. Silveira, Lynn Quek, Itamar S. Santos, Anna Corby, Juan L. Coelho-Silva, Diego A. Pereira-Martins, Grant Vallance, Benjamin Brown, Luciana Nardinelli, Wellington F. Silva, Elvira D. R. P. Velloso, Antonio R. Lucena-Araujo, Fabiola Traina, Andy Peniket, Paresh Vyas, Eduardo M. Rego, Israel Bendit, Vanderson Rocha
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2339–2350.
https://doi.org/10.1182/bloodadvances.2019001419
Published: 2020
Includes: Supplemental data
Journal Articles

A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)

Clinical Trials & Observations
Jeffrey E. Lancet, Anna B. Moseley, Steven E. Coutre, Daniel J. DeAngelo, Megan Othus, Martin S. Tallman, Mark R. Litzow, Rami S. Komrokji, Harry P. Erba, Frederick R. Appelbaum
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1683–1689.
https://doi.org/10.1182/bloodadvances.2019001278
Published: 2020
Journal Articles

Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review

Clinical Trials & Observations
John Y. Rhee, Douglas Tremblay, Amy M. Chan, Martin S. Tallman, John Mascarenhas
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1854–1857.
https://doi.org/10.1182/bloodadvances.2019000249
Published: 2019
Journal Articles

Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia

Coline Gaillard, Sangeetha Surianarayanan, Trevor Bentley, Matthew R. Warr, Briana Fitch, Huimin Geng, Emmanuelle Passegué, Hugues de Thé, Scott C. Kogan
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2462–2466.
https://doi.org/10.1182/bloodadvances.2018018929
Published: 2018
Includes: Supplemental data
Journal Articles

Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice

Jacob T. Jackson, Ashley P. Ng, Benjamin J. Shields, Sue Haupt, Ygal Haupt, Matthew P. McCormack
Journal: Blood Advances
Blood Adv (2018) 2 (4): 347–360.
https://doi.org/10.1182/bloodadvances.2017013243
Published: 2018
Includes: Supplemental data
Journal Articles

Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia

Clinical Trials & Observations
Antonio R. Lucena-Araujo, Diego A. Pereira-Martins, Luisa C. Koury, Pedro L. Franca-Neto, Juan L. Coelho-Silva, Virginia M. de Deus Wagatsuma, Raul A. M. Melo, Rosane Bittencourt, Katia Pagnano, Ricardo Pasquini, Carlos S. Chiattone, Evandro M. Fagundes, Maria de Lourdes Chauffaille, Stanley L. Schrier, Martin S. Tallman, Raul C. Ribeiro, David Grimwade, Arnold Ganser, Bob Löwenberg, Francesco Lo-Coco, Miguel A. Sanz, Nancy Berliner, Eduardo M. Rego
Journal: Blood Advances
Blood Adv (2017) 1 (21): 1807–1814.
https://doi.org/10.1182/bloodadvances.2017005926
Published: 2017
Includes: Supplemental data